Unlock instant, AI-driven research and patent intelligence for your innovation.
A kind of hif-2α small molecule inhibitor and its use
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of HIF-2 and drug delivery route, applied in the field of tumor
Active Publication Date: 2019-12-10
中国医科大学
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] At present, there are few reports on HIF-2α inhibitors. Only Cho et al. found a small molecule PT2399 that can target and inhibit HIF-2α in pVHL-deficient renal cell carcinoma cells, but there is no HIF2 that has effects on other tumors such as breast cancer and ovarian cancer. -alpha inhibitor report
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0072] Example 1: Structure and Identification of HIF-2α Inhibitor
[0073] The applicant used the molecular simulation drug design software MOE to perform pharmacophore screening and molecular docking, and conducted experimental verification based on the final docking advantage structure, thereby screening out the HIF-2α inhibitor of the present invention, showing that pyrimidine[1,2-a] Compounds with pyridine as the core can act as HIF-2α inhibitors, but changes in the substituents on the core can lead to different targets, and the final clinical indications used for treatment may also be different. This type of compound has a higher affinity to the PAS region (such as figure 1 As shown, S=-10.1898). The applicant entrusted Topscience Co., Ltd. to synthesize the HIF-2α inhibitor. The structure of the HIF-2α inhibitor is as follows:
[0074]
[0075]
[0076] Detect the proton spectrum of this compound 1 (ComA), carbon spectrum, respectively as figure 2 with image...
Embodiment 2
[0077] Example 2: Antitumor activity of HIF-2α inhibitors.
[0083] Take out MCF-7 and OVCAR-3 cells from liquid nitrogen, melt them in a water bath at 37°C, centrifuge at 1000rpm for 5 minutes, remove the supernatant, add 1ml of DMEM medium with 10% fetal bovine serum for MCF-7 cells, and transfer the cell suspension into 25c...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the field of tumor diagnosis and treatment, and relates to a small molecule inhibitor of HIF-2α and its use in treating tumors such as breast cancer and ovarian cancer. The small molecule inhibitor is a compound represented by formula (I) or a stereoisomer, a pharmaceutically acceptable salt, a solvate or a prodrug of a compound represented by formula (I), and inhibits HIF‑2α protein mainly by inhibiting The proliferation of tumor cells, at the same time, can inhibit the growth of CSCs with high expression of HIF‑2α, which can be used as a new antitumor drug to completely eliminate tumors and stem cells, and has broad application prospects.
Description
technical field [0001] The invention belongs to the field of tumor diagnosis and treatment, and relates to a small molecule inhibitor of HIF-2α and its use in treating tumors such as breast cancer and ovarian cancer. Background technique [0002] Cancer (cancer) is a malignant tumor. Generally, normal cells in the body undergo abnormal cell differentiation and proliferation due to external stimuli, and their growth is out of control, and they are invasive and metastatic. Cancer stem cells (cancer stem cells, CSCs) are also known as "tumor initiating cells", and the existence of CSCs has been found in various tumors such as breast cancer and ovarian cancer. CSCs are the seeds of tumor occurrence and recurrence, have strong self-renewal ability and multi-directional differentiation potential, and are the root of tumor drug resistance. Because CSCs are in a dormant state, their ability to divide and proliferate is weak, but current radiotherapy and chemotherapy are mainly aime...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
